Clinical Trial Update: Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease [Phase 4]

View source ↗

Summary

Phase 4 trial comparing tacrolimus to prednisolone for minimal change disease has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Minimal Change Disease

Drugs mentioned

• Prednisolone (Prednisolone)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Imperial College Healthcare NHS Trust | Conditions: Minimal Change Disease | Phase 4 | Status: COMPLETED | Results posted: 2021-05-04